Stay updated on CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the record history, and the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-10T15:38:51.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added revision v3.4.2 and removed revision v3.4.1 from the study's record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-17T03:58:47.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.1) was added to the history, and outdated notices about funding and the older revision (v3.4.0) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-10T01:15:50.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added to the page.
    Difference
    0.8%
    Check dated 2026-02-02T21:32:56.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Glossary toggle and color-coded highlights were added, and the revision notice updated to v3.4.0; the No FEAR Act data line was removed.
    Difference
    1%
    Check dated 2026-01-26T21:03:05.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    Record History shows a new revision (v3.3.4) with sponsor Nanjing IASO Biotechnology Co., Ltd., and status notes such as 'Last known status was: Unknown status' and 'Verified'; the previous revision v3.3.3 appears to have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-19T21:55:00.000Z thumbnail image

Stay in the know with updates to CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.